BIOPHEN Prothrombin
For Research Use Only in the United States and Canada
Clotting, Deficient Plasmas, & Chromogenic Assays products are available worldwide
Chromogenic assay for the quantitative determination of Prothrombin in human citrated plasma or in concentrates, using a manual or automated protocol. Highly useful assay for elevated Prothrombin concentrations.
|
Assay characteristics
|
Kit components
|
Applications
|
|
Total Assay Time: 5 min.
Detection Threshold: ≤ 5%
Dynamic Range: 5-200%
Intra-Assay CV: 2 - 5%
Inter-Assay CV: 3 - 6%
Not sensitive to the presence of heparin in plasma up to a concentration of at least 2 IU/mL.
|
R1: 4x2.5 mL Ecarinâ, which specifically activates Prothrombin into meizothrombin
R2: 4x5 mg Chromogenic substrate, specific for Thrombin (SIIa-01)
R3: 4x5 mL x10 concentrated Tris-BSA buffer
|
Congenital or acquired Prothrombin deficiency.
High Prothrombin concentrations associated with G20210A mutation.
Therapeutic concentrates.
|
Download Technical File for BIOPHEN Prothrombin
Streamline laboratory procedures! Click here for ready-to-use reagents and
buffers, from Medicago AB. Available in tablets and pouches!
| INFORMATION |
| SKU ID # |
Packaging |
Package Inserts |
MSDS |
Adaptations |
Price |
| A221605 |
4x50 |
|
|
|
$375.00 |
|
|
Back to Chromogenic assays
|
